Design Therapeutics, Inc.
DSGN
$3.50
-$0.02-0.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.77% | -4.69% | -10.57% | -6.20% | 6.22% |
| Total Depreciation and Amortization | 6.71% | -2.61% | 1.32% | 5.59% | 3.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.92% | 22.07% | -3.87% | 18.74% | 63.16% |
| Change in Net Operating Assets | -205.96% | -3.88% | 224.41% | 54.06% | -47.66% |
| Cash from Operations | -70.27% | -3.29% | 15.22% | 9.48% | 2.81% |
| Capital Expenditure | -- | -100.00% | 109.94% | 17.44% | -622.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 333.52% | 131.36% | -121.25% | 32.11% | 272.82% |
| Cash from Investing | 329.59% | 131.45% | -121.31% | 32.58% | 271.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.25% | 26,200.00% | -99.56% | 1,045.00% | -96.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.25% | 26,200.00% | -99.56% | 1,045.00% | -96.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.57% | 49.48% | -194.29% | 98.88% | 221.58% |